Want to see PBSV full AI Analyst Report?
PBSV Stock Chart & Stats
$0.42
-$0.16(-27.16%)
At close: 4:00 PM EDT
$0.42
-$0.16(-27.16%)
Day’s Range― - ―
52-Week Range$0.42 - $1.36
Previous CloseN/A
Volume2.51K
Average Volume (3M)2.53K
Market Cap
$9.68M
Enterprise Value$11.26M
Total Cash (Recent Filing)$8.47M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Sep 16, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding22,901,691
10 Day Avg. Volume1,930
30 Day Avg. Volume2,531
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)1.04
Price to Sales (P/S)1.38
P/FCF Ratio-55.94
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue1.24
Enterprise Value/Gross Profit3.82
Enterprise Value/Ebitda-96.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.09
Revenue Forecast (FY)$11.50M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetMinimal-to-zero debt materially reduces financial distress risk and interest burden, giving management durable flexibility to fund operations, restructure costs or pursue strategic moves over the next several months even if cash flows remain weak.
Healthy Gross MarginA ~33% gross margin indicates the core service offering retains meaningful markup versus direct costs, which supports longer-term profitability if operating expenses are controlled. This structural margin provides a foundation for sustained recovery efforts.
Equity-dominated Capital BaseA capital structure dominated by equity preserves solvency and reduces refinancing risk, enabling the company to withstand short-term cash burn and pursue operational fixes or investments without large interest obligations that would erode margins.
Bears Say
Negative Operating And Free Cash FlowPersistent negative operating and free cash flow is a durable red flag: it forces reliance on external financing or asset sales, limits reinvestment ability, and increases execution risk over the next several months despite low leverage.
Volatile ProfitabilityWide swings in profitability and an unusual TTM rebound undermine predictability of earnings and operational planning. Structural volatility reduces confidence in margin sustainability and complicates budgeting and long-term contract negotiations.
Weak Return On EquityVery low or negative ROE signals poor capital efficiency: the business has struggled to convert equity into durable profits. Over months, this limits ability to generate shareholder value and justifies scrutiny of strategy and cost structure.
Pharma Bio Services News
PBSV FAQ
What was Pharma Bio Services’s price range in the past 12 months?
Pharma Bio Services lowest stock price was $0.42 and its highest was $1.36 in the past 12 months.
What is Pharma Bio Services’s market cap?
Pharma Bio Services’s market cap is $9.68M.
When is Pharma Bio Services’s upcoming earnings report date?
Pharma Bio Services’s upcoming earnings report date is Sep 16, 2026 which is in 51 days.
How were Pharma Bio Services’s earnings last quarter?
Pharma Bio Services released its earnings results on Jun 15, 2026. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.02.
Is Pharma Bio Services overvalued?
According to Wall Street analysts Pharma Bio Services’s price is currently Overvalued.
Does Pharma Bio Services pay dividends?
Pharma Bio Services pays a Notavailable dividend of $0.075 which represents an annual dividend yield of N/A. See more information on Pharma Bio Services dividends here
What is Pharma Bio Services’s EPS estimate?
Pharma Bio Services’s EPS estimate is 0.03.
How many shares outstanding does Pharma Bio Services have?
Pharma Bio Services has 22,901,691 shares outstanding.
What happened to Pharma Bio Services’s price movement after its last earnings report?
Pharma Bio Services reported an EPS of $0.01 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharma Bio Services?
Currently, no hedge funds are holding shares in PBSV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pharma Bio Services
Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.
Technical Analysis
Zhongchao
―
Healthcare Triangle
―
VSee Health
―
Aclarion, Inc.
―
BullFrog AI Holdings, Inc.
―